Trial reportLasers in surgery and medicine2026
Comparative Efficacy and Safety of 1064-nm Picosecond Laser and 1927-nm Fractional Thulium Laser for Atrophic Acne Scars in Asian Patients: A Prospective, Randomized, Split-Face Study.
Trial report in Lasers in surgery and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAtrophic acne scars are a common sequela of inflammatory acne, resulting from abnormal dermal remodeling due to imbalance in collagen synthesis and degradation. Laser therapies, including picosecond and fractional lasers, have emerged as effective treatments, yet direct comparative studies remain limited.
objectiveTo compare the efficacy, safety, and tolerability of 1064-nm microlens array picosecond laser (P-MLA) versus 1927-nm sub-ablative fractional thulium laser (FTL) in Asian patients with atrophic acne scars.
methodsThis prospective, single-center, evaluator-blinded, randomized trial employed a split-face design. Thirty-five patients with symmetric facial atrophic acne scars received three sessions of P-MLA on one side and FTL on the contralateral side at 4-week intervals. Clinical outcomes were assessed using ECCA scores and blinded physician GAIS. Objective skin parameters (TEWL, MI, and EI) were measured, and patient satisfaction and adverse events were recorded.
resultsBoth lasers significantly improved ECCA scores compared to baseline (P-MLA: 102.86 ± 47.47 → 86.86 ± 47.42, p < 0.001; FTL: 101.43 ± 44.89 → 85.57 ± 50.54, p < 0.001), with no significant difference between sides. GAIS score was significantly higher on the P-MLA side (2.83 ± 1.272 vs. 2.57 ± 1.243, p = 0.037). P-MLA demonstrated lower MI and EI at 3 months post-treatment, reduced intraoperative pain, shorter crusting duration, and minimal social downtime, whereas FTL exhibited higher crusting and erythema. TEWL returned to baseline for both groups. Patient satisfaction was high and comparable between sides.
conclusionBoth P-MLA and FTL are effective for treating atrophic acne scars in Asian patients, demonstrating comparable clinical efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.